Jacob Steven Leach sold $991K of DexCom (DXCM)

Executed Mar 12 2025, disclosed Mar 14 2025, 2 days later.

Value, as filed

$991K

14,076 sh × $70.38

Executed

Mar 12 2025

the trade date, as filed

Disclosed

Mar 14 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Jacob Steven Leach President & COO profile →

Jacob Steven Leach (President & COO) filed 1 Form 4 report in the trailing twelve months (1 purchase, 0 sales), most often in DexCom, Inc. (DXCM). Across 1 priced purchase filing, the average 21-session return was +20.3% from execution and +20.3% from disclosure (delay-adjusted; derived). The largest single filing was $1.0M of DXCM (18,200 sh across 2 lots, as filed), executed Nov 10 2025.

The name

DXCM

DexCom, Inc. DXCM · Healthcare · 52 filings in 24 months ticker →

Healthcare · DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) sy…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Jacob Steven Leach in DXCM

DXCMPURCHASE DexCom, Inc. $1.0M
18,200 sh across 2 lots
Exec Nov 10 2025
Filed Nov 10 2025 · 7:13 PM ET DXCMSALE DexCom, Inc. $229K
2,634 sh × $86.91
Exec Jan 29 2025
Filed Jan 30 2025 · 5:30 PM ET